Cargando…

Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia

BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Trent, Mallory, Seale, Holly, Chughtai, Abrar Ahmad, Salmon, Daniel, MacIntyre, C. Raina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220944/
https://www.ncbi.nlm.nih.gov/pubmed/34218963
http://dx.doi.org/10.1016/j.vaccine.2021.06.048
_version_ 1783711240445493248
author Trent, Mallory
Seale, Holly
Chughtai, Abrar Ahmad
Salmon, Daniel
MacIntyre, C. Raina
author_facet Trent, Mallory
Seale, Holly
Chughtai, Abrar Ahmad
Salmon, Daniel
MacIntyre, C. Raina
author_sort Trent, Mallory
collection PubMed
description BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-sectional survey of adults from Dynata’s research panel in July-September 2020. PARTICIPANTS, SETTING: Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. MAIN OUTCOMES AND MEASURES: Willingness to receive a COVID-19 vaccine; reason for vaccine intention. STATISTICAL METHODS: To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios. RESULTS: The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07–1.44 and PR = 1.38; 95% CI = 1.74–1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72–0.85 and PR = 0.85; 95% CI = 0.76–0.96). LIMITATIONS: Consumer panels can be subject to bias and may not be representative of the general population. CONCLUSIONS: Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine.
format Online
Article
Text
id pubmed-8220944
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82209442021-06-23 Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia Trent, Mallory Seale, Holly Chughtai, Abrar Ahmad Salmon, Daniel MacIntyre, C. Raina Vaccine Article BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-sectional survey of adults from Dynata’s research panel in July-September 2020. PARTICIPANTS, SETTING: Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. MAIN OUTCOMES AND MEASURES: Willingness to receive a COVID-19 vaccine; reason for vaccine intention. STATISTICAL METHODS: To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios. RESULTS: The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07–1.44 and PR = 1.38; 95% CI = 1.74–1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72–0.85 and PR = 0.85; 95% CI = 0.76–0.96). LIMITATIONS: Consumer panels can be subject to bias and may not be representative of the general population. CONCLUSIONS: Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine. The Authors. Published by Elsevier Ltd. 2022-04-14 2021-06-23 /pmc/articles/PMC8220944/ /pubmed/34218963 http://dx.doi.org/10.1016/j.vaccine.2021.06.048 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Trent, Mallory
Seale, Holly
Chughtai, Abrar Ahmad
Salmon, Daniel
MacIntyre, C. Raina
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
title Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
title_full Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
title_fullStr Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
title_full_unstemmed Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
title_short Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
title_sort trust in government, intention to vaccinate and covid-19 vaccine hesitancy: a comparative survey of five large cities in the united states, united kingdom, and australia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220944/
https://www.ncbi.nlm.nih.gov/pubmed/34218963
http://dx.doi.org/10.1016/j.vaccine.2021.06.048
work_keys_str_mv AT trentmallory trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia
AT sealeholly trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia
AT chughtaiabrarahmad trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia
AT salmondaniel trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia
AT macintyrecraina trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia